| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.02 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |